STAAR Surgical Company
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collame…
Medical - Instruments & Supplies
US, Lake Forest [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
1
Financial Health
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Current Ratio | 3.90 | 5.84 | 5.62 | |
| Debt/Assets | n.A. | n.A. | n.A. | |
| Debt/Equity | n.A. | n.A. | n.A. | |
| Net Debt/EBITDA | 1342.48 | 180.39 | -12.51 | |
| Naive Interpretation | member | |||
2
Per Share
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Book Value | 1.58 | 8.03 | 7.91 | |
| Cash | 10.86 | 5.01 | 4.52 | |
| Capex | -68.14 | -0.11 | -0.06 | |
| Free Cash Flow | -43.05 | 0.34 | 0.59 | |
| Revenue | 1.23 | 1.58 | 1.56 | |
| Naive Interpretation | member | |||
3
Profitability
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Gross Margin | -0.90 | 0.79 | 0.80 | |
| Operating Margin | -78.38 | -0.03 | 0.14 | |
| ROA | -57.29 | < 0.005 | 0.02 | |
| ROE | -57.70 | < 0.005 | 0.02 | |
| ROIC | -42.27 | < 0.005 | 0.01 | |
| Naive Interpretation | member | |||
4
Valuation
The "Valuation Entry" for the Focus of STAA is permitted for members.
5
Growth
The "Growth Entry" for the Focus of STAA is permitted for members.
6
Leverage & Liquidity